SSY Group Ltd LJUIF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.66
- Day Range
- $0.70–0.70
- 52-Week Range
- $0.70–0.70
- Bid/Ask
- $0.58 / $0.64
- Market Cap
- $2.08 Bil
- Volume/Avg
- 710 / 710
Key Statistics
- Price/Earnings (Normalized)
- 14.52
- Price/Sales
- 2.54
- Dividend Yield (Trailing)
- 2.55%
- Dividend Yield (Forward)
- 2.55%
- Total Yield
- 3.22%
Company Profile
SSY Group Ltd is engaged in the research, development, manufacturing and selling of a wide range of pharmaceutical products, which includes finished medicines of mainly intravenous infusion solution and ampoule injection to hospitals and distributors, bulk pharmaceuticals and medical materials. The company has two reportable segments including intravenous infusion solution and others and medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products, followed by medical materials.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 5,600
- Website
- https://www.ssygroup.com.hk
Comparables
Valuation
|
Metric
|
LJUIF
|
01061
|
00867
|
|---|---|---|---|
Price/Earnings (Normalized) | 14.52 | 4.51 | 6.32 |
Price/Book Value | 2.61 | 0.65 | 1.01 |
Price/Sales | 2.54 | 0.76 | 1.94 |
Price/Cash Flow | 10.94 | 3.46 | 6.35 |
Price/Earnings
LJUIF
01061
00867
Financial Strength
|
Metric
|
LJUIF
|
01061
|
00867
|
|---|---|---|---|
Quick Ratio | 1.58 | 1.42 | 3.91 |
Current Ratio | 2.03 | 1.54 | 4.29 |
Interest Coverage | 13.36 | 30.76 | 59.97 |
Quick Ratio
LJUIF
01061
00867
Profitability
|
Metric
|
LJUIF
|
01061
|
00867
|
|---|---|---|---|
Return on Assets (Normalized) | 11.72% | 9.95% | 14.91% |
Return on Equity (Normalized) | 20.66% | 15.33% | 17.41% |
Return on Invested Capital (Normalized) | 13.93% | 12.40% | 15.18% |
Return on Assets
LJUIF
01061
00867
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Rqyyrtpkh | Wtsvmr | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Btbyyffbmg | Lwkl | $68.9 Bil | |
HLN
| Haleon PLC ADR | Fyskqyxfv | Kfnl | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vbdqjdhf | Glwk | $14.7 Bil | |
VTRS
| Viatris Inc | Fkgsqqfd | Fbf | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Fyqjcfq | Vckmq | $11.9 Bil | |
CTLT
| Catalent Inc | Kzlzqcymr | Rctjl | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Ssjjbdhzq | Pnzpw | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Hwqvtlp | Rppn | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Rgwnhwq | Tqzjb | $3.5 Bil |